| TIDM | Instrument | Type | Currency | Venue |
|---|---|---|---|---|
| CRMD | CRMD | Shares | USD | XNMS |
| TIDM | Instrument | Type | Currency | Venue |
|---|---|---|---|---|
| CRMD | CRMD | Shares | USD | XNMS |
CorMedix Inc. develops and commercializes therapeutic products aimed at treating life-threatening diseases and conditions. The company focuses on its lead product, DefenCath®, which combines taurolidine and heparin for use in medical applications. CorMedix operates primarily in the healthcare sector, targeting hospitals and healthcare providers as its main customers.
No recent RNS announcements for CRMD across CRMD.
No recent RNS announcements for CRMD across CRMD.